Health Discovery Corp (HDVY)

[you_asked_for_it]

You are a very rare sign of intelligent life here, so I am not going to argue with you. But what you are missing is that I am having a little fun with these characters. At the same time I am trying to stimulate their brain cells so as to make them useful, but apparently to no avail.

OK, you were not referring to the Gen-Probe PAC3 test. I thought you might be, since that is the only gene expression prostate cancer test that I am aware of that is covered by Medicare. And it gives a good apples-to-apples indication on how the HDVY urine test could be accepted by Medicare.

Again, typically the PCA3 test is done after a negative biopsy, that would have been prompted by an elevated PSA test. It is not indicated for use in place of, or in conjunction with PSA, as a screening test.

Let's call it around $275. And Medicare should be thrilled to pay that to avoid unnecessary biopsies and end of life treatments for cancers that might have been cured with early intervention. Contrary to popular belief, many cancers are cured with the treatments that are currently available.

Bottom line is, the HDVY-Quest-Abbott PC screening test is very likely superior to the PCA3 test, both in sensitivity and specificity. Medicare should have no problem covering it, when it becomes available commercially (initially as a laboratory developed test). Do you concur, Mr Zeno?